INHIBITION OF PROTEIN-KINASE-C BY CATIONIC AMPHIPHILES

被引:128
|
作者
BOTTEGA, R [1 ]
EPAND, RM [1 ]
机构
[1] MCMASTER UNIV,HLTH SCI CTR,DEPT BIOCHEM,1200 MAIN ST W,HAMILTON L8N 3Z5,ONTARIO,CANADA
关键词
D O I
10.1021/bi00152a045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A large number of PKC inhibitors are positively charged. We evaluated the structural features of cationic amphiphiles which are necessary for inhibiting PKC. Many of these compounds were derivatives of cholesterol, which possesses a hydrophobic backbone which does not perturb hydrocarbon packing in membrane bilayers. In addition, they contain a tertiary or quaternary nitrogen functionality in the head group. All designed cholesterol-based amphiphiles inhibit PKC activity; the potency of the amphiphile correlates with the presence of positive charge. Quaternary ammonium amphiphiles are 10-fold more potent than their tertiary amine counterparts, generally inhibiting in the 10-60-mu-M range using the Triton mixed micelle assay. Aside from charge, factors such as the structure of the amine-containing head group, its length from the hydrocarbon moiety, or the number of amine groups on the amphiphile did not markedly influence inhibitor potency. In contrast, the hydrocarbon backbone did influence potency: cationic amphiphiles containing a steroid backbone were more potent inhibitors of PKC than their straight-chain analogues. Changing the nature of the hydrocarbon from a sterol to an alkyl group lowers the pK of the amine head group so that the straight-chain analogues are no longer cationic in the conditions in the PKC assay. The results of these studies suggest that a combination of positive charge and a bilayer-stabilizing structural characteristic provides a basis for the rational design of PKC inhibitors.
引用
收藏
页码:9025 / 9030
页数:6
相关论文
共 50 条
  • [1] CATIONIC AMPHIPHILES CAN ALTER THE SUBSTRATE-SPECIFICITY OF PROTEIN-KINASE-C
    EPAND, RM
    BRUINS, RH
    GIORGIONE, J
    [J]. FASEB JOURNAL, 1994, 8 (07): : A1230 - A1230
  • [2] TAMOXIFEN INHIBITION OF PROTEIN-KINASE-C
    HORGAN, K
    COOKE, E
    HALLETT, MB
    MANSEL, RE
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (06): : 731 - 731
  • [3] MECHANISM OF PROTEIN-KINASE-C INHIBITION BY SPHINGOSINE
    BAZZI, MD
    NELSESTUEN, GL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 146 (01) : 203 - 207
  • [4] CROMOLYN INHIBITION OF PROTEIN-KINASE-C ACTIVITY
    LUCAS, AM
    SHUSTER, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (04) : 562 - 565
  • [5] INHIBITION OF PROTEIN-KINASE-C IN THE CEREBRAL MICROCIRCULATION
    HANSONPAINTON, O
    MOORE, P
    GRAMMAS, P
    [J]. FASEB JOURNAL, 1995, 9 (06): : A1409 - A1409
  • [6] INHIBITION OF PROTEIN-KINASE-C AND PROTEIN-TYROSINE KINASE BY SILYBINS
    CHANG, SC
    CHEN, DH
    ASHENDEL, CL
    GEAHLEN, RL
    CHAN, CJ
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 52 - MEDI
  • [7] INHIBITION OF PROTEIN-KINASE-C BY ALCOHOLS AND ANESTHETICS
    SLATER, SJ
    COX, KJA
    LOMBARDI, JV
    HO, C
    KELLY, MB
    RUBIN, E
    STUBBS, CD
    [J]. NATURE, 1993, 364 (6432) : 82 - 84
  • [8] INHIBITION OF PROTEIN-KINASE-C BY THE TYROSINE KINASE INHIBITOR ERBSTATIN
    BISHOP, WR
    PETRIN, J
    WANG, L
    RAMESH, U
    DOLL, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (09) : 2129 - 2135
  • [9] FLAVONOID INHIBITION OF PROTEIN-KINASE-C (PK C) ACTIVITY
    FERRIOLA, PC
    NARINS, C
    MIDDLETON, E
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (01) : 174 - 174
  • [10] INHIBITION OF PROTEIN-KINASE-C BY LOCAL-ANESTHETICS
    TRUDELL, JR
    COSTA, AK
    HUBBELL, WL
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 625 : 743 - 746